Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1962 1
1963 2
1968 1
1972 1
1975 1
1977 2
1978 3
1979 1
1980 2
1981 1
1982 2
1985 1
1987 1
1988 2
1993 1
1994 1
1996 3
1997 3
1998 2
2000 3
2007 1
2008 2
2009 2
2010 5
2011 3
2012 6
2013 4
2014 9
2015 8
2016 6
2017 3
2018 3
2019 7
2020 13
2021 9
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Results by year
Filters applied: . Clear all
Page 1
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection.
Jones BE, Brown-Augsburger PL, Corbett KS, Westendorf K, Davies J, Cujec TP, Wiethoff CM, Blackbourne JL, Heinz BA, Foster D, Higgs RE, Balasubramaniam D, Wang L, Bidshahri R, Kraft L, Hwang Y, Žentelis S, Jepson KR, Goya R, Smith MA, Collins DW, Hinshaw SJ, Tycho SA, Pellacani D, Xiang P, Muthuraman K, Sobhanifar S, Piper MH, Triana FJ, Hendle J, Pustilnik A, Adams AC, Berens SJ, Baric RS, Martinez DR, Cross RW, Geisbert TW, Borisevich V, Abiona O, Belli HM, de Vries M, Mohamed A, Dittmann M, Samanovic M, Mulligan MJ, Goldsmith JA, Hsieh CL, Johnson NV, Wrapp D, McLellan JS, Barnhart BC, Graham BS, Mascola JR, Hansen CL, Falconer E. Jones BE, et al. Among authors: dittmann m. bioRxiv. 2020 Oct 1:2020.09.30.318972. doi: 10.1101/2020.09.30.318972. Preprint. bioRxiv. 2020. PMID: 33024963 Free PMC article. Updated.
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.
Lokugamage KG, Hage A, de Vries M, Valero-Jimenez AM, Schindewolf C, Dittmann M, Rajsbaum R, Menachery VD. Lokugamage KG, et al. Among authors: dittmann m. J Virol. 2020 Nov 9;94(23):e01410-20. doi: 10.1128/JVI.01410-20. Print 2020 Nov 9. J Virol. 2020. PMID: 32938761 Free PMC article.
SARS-CoV-2 is sensitive to type I interferon pretreatment.
Lokugamage KG, Hage A, de Vries M, Valero-Jimenez AM, Schindewolf C, Dittmann M, Rajsbaum R, Menachery VD. Lokugamage KG, et al. Among authors: dittmann m. bioRxiv. 2020 Apr 9:2020.03.07.982264. doi: 10.1101/2020.03.07.982264. Preprint. bioRxiv. 2020. PMID: 32511335 Free PMC article. Updated.
Identification of a nerve-associated, lung-resident interstitial macrophage subset with distinct localization and immunoregulatory properties.
Ural BB, Yeung ST, Damani-Yokota P, Devlin JC, de Vries M, Vera-Licona P, Samji T, Sawai CM, Jang G, Perez OA, Pham Q, Maher L, Loke P, Dittmann M, Reizis B, Khanna KM. Ural BB, et al. Among authors: dittmann m. Sci Immunol. 2020 Mar 27;5(45):eaax8756. doi: 10.1126/sciimmunol.aax8756. Sci Immunol. 2020. PMID: 32220976 Free PMC article.
S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2.
Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, Hamm H, Höger P, Horneff G, von Kiedrowski R, Philipp S, Pleimes M, Schlaeger M, Schuster V, Staubach P, Weberschock T, Werner RN, Nast A, Sticherling M. Eisert L, et al. Among authors: dittmann m. J Dtsch Dermatol Ges. 2019 Sep;17(9):959-973. doi: 10.1111/ddg.13936. J Dtsch Dermatol Ges. 2019. PMID: 31538732
S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 1.
Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, Hamm H, Höger P, Horneff G, von Kiedrowski R, Philipp S, Pleimes M, Schläger M, Schuster V, Staubach P, Weberschock T, Werner RN, Nast A, Sticherling M. Eisert L, et al. Among authors: dittmann m. J Dtsch Dermatol Ges. 2019 Aug;17(8):856-870. doi: 10.1111/ddg.13907. J Dtsch Dermatol Ges. 2019. PMID: 31437363
S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 2.
Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, Hamm H, Höger P, Horneff G, von Kiedrowski R, Philipp S, Pleimes M, Schlaeger M, Schuster V, Staubach P, Weberschock T, Werner RN, Nast A, Sticherling M. Eisert L, et al. Among authors: dittmann m. J Dtsch Dermatol Ges. 2019 Sep;17(9):959-974. doi: 10.1111/ddg.13936_g. J Dtsch Dermatol Ges. 2019. PMID: 31538739 German.
S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 1.
Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, Hamm H, Höger P, Horneff G, von Kiedrowski R, Philipp S, Pleimes M, Schlaeger M, Schuster V, Staubach P, Weberschock T, Werner RN, Nast A, Sticherling M. Eisert L, et al. Among authors: dittmann m. J Dtsch Dermatol Ges. 2019 Aug;17(8):856-870. doi: 10.1111/ddg.13907_g. J Dtsch Dermatol Ges. 2019. PMID: 31437372 German.
Comparative study of a 3CL pro inhibitor and remdesivir against both major SARS-CoV-2 clades in human airway models.
de Vries M, Mohamed AS, Prescott RA, Valero-Jimenez AM, Desvignes L, O'Connor R, Steppan C, Devlin JC, Ivanova E, Herrera A, Schinlever A, Loose P, Ruggles K, Koralov SB, Anderson AS, Binder J, Dittmann M. de Vries M, et al. Among authors: dittmann m. bioRxiv. 2020 Aug 28:2020.08.28.272880. doi: 10.1101/2020.08.28.272880. Preprint. bioRxiv. 2020. PMID: 32869028 Free PMC article.
101 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page